Loading clinical trials...
Loading clinical trials...
The goal of this randomized, double-blind, placebo controlled, Multicenter Phase II clinical trial is to initially evaluate the Safety and Efficacy of MT2004 Capsule in Cholestatic and Mixed drug indu...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Xi'An Aolitai Pharmaceutical Technology Co Ltd
NCT06872372 · Acute Liver Failure, Drug-Induced Liver Injury
NCT05517668 · Acetaminophen, Drug Overdose, and more
NCT03100786 · Tuberculosis, Tuberculous Meningitis, and more
NCT03211208 · Drug-Induced Liver Injury, Anti-Tuberculous Drug Reaction, and more
NCT05465642 · Drug-induced Liver Injury, Gut Microbiota, and more
Shanghai Jiaotong University School of Medicine,Renji Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions